Detalhe da pesquisa
1.
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms.
Blood
; 141(8): 917-929, 2023 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36356299
2.
Hematoxylin binds to mutant calreticulin and disrupts its abnormal interaction with thrombopoietin receptor.
Blood
; 137(14): 1920-1931, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33202418
3.
CDK6 coordinates JAK2 V617F mutant MPN via NF-κB and apoptotic networks.
Blood
; 133(15): 1677-1690, 2019 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30635286
4.
Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants.
Blood
; 133(25): 2669-2681, 2019 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30902807
5.
Hematopoietic expression of a chimeric murine-human CALR oncoprotein allows the assessment of anti-CALR antibody immunotherapies in vivo.
Am J Hematol
; 96(6): 698-707, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33761144
6.
Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer.
Angiogenesis
; 23(2): 159-177, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31667643
7.
High activation of STAT5A drives peripheral T-cell lymphoma and leukemia.
Haematologica
; 105(2): 435-447, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31123029
8.
Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis.
Blood
; 127(10): 1317-24, 2016 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26608331
9.
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants.
Blood
; 127(10): 1325-35, 2016 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26668133
10.
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms.
Blood
; 127(3): 325-32, 2016 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26423830
11.
Co-expression of mutated Jak2 and Calr enhances myeloproliferative phenotype in mice without loss of stem cell fitness.
Am J Hematol
; 97(11): E396-E399, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36053947
12.
Somatic mutations of calreticulin in myeloproliferative neoplasms.
N Engl J Med
; 369(25): 2379-90, 2013 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24325356
13.
STAT5 is Expressed in CD34+/CD38- Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms.
Cancers (Basel)
; 12(4)2020 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32326377
14.
A novel germline JAK2 mutation in familial myeloproliferative neoplasms.
Am J Hematol
; 89(1): 117-8, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24142793
15.
Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.
Cell Death Dis
; 10(8): 605, 2019 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31406155
16.
Correction: The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth.
Oncotarget
; 9(73): 33865, 2018 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30333916
17.
STAT5BN642H is a driver mutation for T cell neoplasia.
J Clin Invest
; 128(1): 387-401, 2018 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29200404
18.
Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.
Cell Death Dis
; 9(8): 800, 2018 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30038364
19.
The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth.
Oncotarget
; 7(32): 51096-51106, 2016 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27191495
20.
Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.
Cell Death Dis
; 7(10): e2419, 2016 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27735950